GeneBio Systems
Recombinant Mouse HVEM/TNFRSF14 Protein (His & Fc Tag)
Recombinant Mouse HVEM/TNFRSF14 Protein (His & Fc Tag)
SKU:PKSM040930
Couldn't load pickup availability
Size: 100μg
Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping: This product is provided as lyophilized powder which is shipped with ice packs.
Exp date: 12 months
Category ID_II: Recombinant Proteins
Category ID_III: Immune Checkpoint Proteins
Abbreviation:
Target Synonym: ATAR;Atar;HVEM;Herpesvirus entry mediator;HveA;TNF receptor-like molecule;TR2;Tnfrsf14;Tumor necrosis factor receptor superfamily member 14;another TRAF-associated receptor
Research Areas:
Conjugation:
Target Species: Mouse
Expression Host: HEK293 Cells
Application: ELISA
Fusion tag: C-His-Fc
UNIProt ID: Q80WM9
Accession: NP_849262.1
Background: Herpesvirus entry mediator (HVEM), also referred to as TNFRSF14, TR2 (TNF receptor-like molecule) and ATAR (another TRAF-associated receptor), is a member of type I transmembrane protein belonging to the TNF-receptor superfamily. It is expressed on many immune cells, including T and B cells, NK cells, monocytes, and neutrophils. Two TNF superfamily ligands lymphotoxin α (TNF-β) and LIGHT (TNFSF14) are identified as cellular ligands for HVEM and initiate the positive signaling. However, recent studies have revealed that HVEM is also involved in the unique inhibitory signaling pathway for T cells through activating tyrosine phosphorylation of the immunoreceptor tyrosine-based inhibitory motif (ITIM) in B and T lymphocyte attenuator (BTLA). HVEM provides a stimulatory signal following engagement with LIGHT (TNFSF14) on T cells. In contrast, it can also provide an inhibitory signal to T cells when it binds the B and T lymphocyte attenuator (BTLA), a ligand member of the Immunoglobulin (Ig) superfamily. Thus, HVEM may be viewed as a molecular switch, capable of facilitating both stimulatory and inhibitory cosignaling in T cells. Substantial evidence from both human disease and from experimental mouse models has indicated that dysregulation of the LIGHT-HVEM-BTLA cosignaling pathway can cause inflammation in the lung and in mucosal tissues.
Concentration:
Activity: Immobilized mouse HVEM-Fch at 10 μg/mL (100 μl/well) can bind biotinylated mouse BTLA-Fc, The EC50 of biotinylated mouse BTLA-Fcis 64-96 ng/mL.
Sequence: Met 1-Gln 206
Purity: > 90 % as determined by reducing SDS-PAGE.
Formulation: Lyophilized from sterile PBS, pH 7.4
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution: Please refer to the printed manual for detailed information.
Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
Calculated MW: 46.4 kDa
ObservedMW: 65 kDa
